Biotech · Private company
TORL Biotherapeutics, LLC
Track this companyFree. Adds TORL Biotherapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials87 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- Pegfilgrastim (drug)Phase 2 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- TORL-1-23Phase 2 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- TORL-1-23 and carboplatinPhase 2 · FIGO Stage III and IV Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- TORL-1-23 and paclitaxelPhase 2 · FIGO Stage III and IV Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- TORL-1-23, paclitaxel, and carboplatinPhase 2 · FIGO Stage III and IV Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- TORL-5-700Phase 2 · Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TORL-5-700 at MTD/RP2DPhase 2 · Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TORL-5-700 at MTD/RP2D in combination with another agentPhase 2 · Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- TORL-1-23Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TORL-2-307-ADCPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TORL-2-307-MABPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TORL-3-600Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- TORL-4-500Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's LymphomaPHASE1_PHASE2 · RECRUITING · started Mar 31, 2026ClinicalTrials.gov NCT07439653 · fetched Nov 12, 2026
- CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian CancerPHASE1_PHASE2 · RECRUITING · started Dec 10, 2025ClinicalTrials.gov NCT07322094 · fetched Nov 12, 2026
- CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.PHASE2 · RECRUITING · started Nov 20, 2024ClinicalTrials.gov NCT06690775 · fetched Nov 12, 2026
- A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 4, 2023ClinicalTrials.gov NCT06005740 · fetched Nov 12, 2026
- First in Human Study of TORL-3-600 in Participants With Advanced CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 29, 2023ClinicalTrials.gov NCT05948826 · fetched Nov 12, 2026
- First in Human Study of TORL-2-307-ADC in Participants With Advanced CancerPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 2, 2022ClinicalTrials.gov NCT05156866 · fetched Nov 12, 2026
- First in Human Study of TORL-2-307-MAB in Participants With Advanced CancerPHASE1 · UNKNOWN · started Jan 20, 2022ClinicalTrials.gov NCT05159440 · fetched Nov 12, 2026
- First in Human Study of TORL-1-23 in Participants With Advanced CancerPHASE1 · RECRUITING · started Nov 17, 2021ClinicalTrials.gov NCT05103683 · fetched Nov 12, 2026